emocha is being used to measure true medication adherence for post-surgery transplant patients with three partners: the Johns Hopkins University, the University of Virginia, and the University of Florida. This project is being funded by the National Institutes of Health’s National Institute on Diabetes and Digestives and Kidney Diseases (NIDDK). Researchers indicates that over a quarter of kidney transplant patients and between 15 percent and 40 percent of liver transplant patients do not take medications as prescribed, putting them at risk of adverse effects including hospitalization and death – and costing health systems up to $11,000 per patient per year. Other harmful effects of non-adherence for transplant patients can include organ rejection graft failure. This study will evaluate how emocha’s video Directly Observed Therapy platform can better support kidney and liver transplant recipients in their immunosuppressive adherence.

Read the full article in mHealth Intelligence